Comprehensive analysis of one of the largest datasets with harmonized variant calls from over 8,000 cancer whole genomes enables researchers worldwide to uncover rare drivers, new targets, and AI-ready insights that could reshape precision oncology. SAN DIEGO–(BUSINESS WIRE)–#BroadInstitute–Researchers at Inocras, a bioinformatics-led precision health company harnessing the power of whole-genome sequencing (WGS) data and proprietary … [Read more…]

Preclinical research with VS-7375 in combination with PRMT5 inhibitors demonstrated strong durable tumor regressions in KRAS G12D pancreatic cancer models In preclinical pancreatic, lung, and colorectal cancer models, VS-7375 (dual ON/OFF inhibitor) showed deeper and more sustained tumor regression compared to ON-only G12D or pan-RAS inhibitors BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed … [Read more…]

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September … [Read more…]

Franklin Templeton specialty investment manager acquires three inpatient rehabilitation facilities on behalf of fund investors SAN MATEO, Calif.–(BUSINESS WIRE)–Franklin Templeton, a global investment leader and its specialist investment manager, Clarion Partners, today announced Clarion Partners Real Estate Income Fund Inc.’s (NASDAQ: CPREX) acquisition of three healthcare real estate properties across Texas, Florida, and Colorado. The … [Read more…]

Brand refresh reflects growing industry focus on protecting patient affordability investments and improving visibility across the Gross-to-Net ecosystem IRVINE, Calif.–(BUSINESS WIRE)–#GTN—RIS Rx today announced a new brand identity and messaging platform reflecting its expanding role in addressing one of the pharmaceutical industry’s most persistent financial and operational challenges: Gross-to-Net (GTN) revenue leakage. The refreshed brand … [Read more…]

Clinical leaders to share actionable insights to help post-acute providers strengthen care processes and improve patient outcomes in value-based care BALTIMORE–(BUSINESS WIRE)–Real Time Medical Systems (Real Time), the industry-leading, KLAS Rated, and HITRUST Certified post-acute analytics solution, announced today its participation in the American Association for Post-Acute Care Nursing (AAPACN) 2026 Conference, taking place March … [Read more…]

Total Expected Revenues from the Three Projects Increase from C$68 Million to C$85 Million TREVIGLIO, Italy & BURLINGTON, Ontario–(BUSINESS WIRE)–An Italian subsidiary of Anaergia Inc. (“Anaergia,” the “Company,” “we,” or “our”) (TSX: ANRG) (OTCQX: ANRGF), Anaergia S.r.l., signed amendments to three previously announced contracts with an entity owned by QGM S.à.r.l. (“QGM”), relating to the … [Read more…]

GENT, Belgium & TOKYO–(BUSINESS WIRE)–#IVD–H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Europe N.V. has obtained a CE Certificate of the Lumipulse G NfL Blood assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows … [Read more…]

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Sonendo, Inc. (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today reported select preliminary financial results for the year ended December 31, 2025 and other business updates. Select Financial Updates1 Generated $28.6 million of total revenue for the full year of 2025, including $23.4 million, … [Read more…]

SALT LAKE CITY–(BUSINESS WIRE)–PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced today that it will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Tuesday, March 17, 2026. Jason Murray, Chief Executive Officer … [Read more…]